Lido Advisors, LLC Bristol Myers Squibb CO Put Options Transaction History

Lido Advisors, LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $68,425 - $90,083	1,700 Added 30.91%	7,200 $299,000
Q1 2024 May 15, 2024	SELL	$47.98 - $54.4 $316,668 - $359,040	-6,600 Reduced 54.55%	5,500 $298,000
Q2 2023 Aug 09, 2023	SELL	$63.71 - $70.74 $159,275 - $176,850	-2,500 Reduced 17.12%	12,100 $773,000
Q1 2023 May 15, 2023	BUY	$65.71 - $74.53 $216,842 - $245,949	3,300 Added 29.2%	14,600 $1.01 Million
Q4 2022 Feb 14, 2023	SELL	$68.48 - $81.09 $301,312 - $356,796	-4,400 Reduced 28.03%	11,300 $812,000
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $181,550 - $199,950	2,500 Added 18.94%	15,700 $1.21 Million
Q1 2022 May 17, 2022	BUY	$61.48 - $73.72 $811,536 - $973,104	13,200 New	13,200 $963,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Lido Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Lido Advisors, LLC with notifications on news.